871P - Safety, clinical activity and biomarkers of atezolizumab (atezo) in advanced ovarian cancer (OC)

Autor: Infante, J.R., Braiteh, F., Emens, L.A., Balmanoukian, A.S., Oaknin, A., Wang, Y., Liu, B., Molinero, L., Fasso, M., O'Hear, C., Gordon, M.
Zdroj: In Annals of Oncology 1 October 2016 27 Supplement 6:vi300-vi300
Databáze: ScienceDirect